Statera Biopharma Inc.

0.00
-0.00 (-100.00%)
At close: Feb 10, 2025, 9:30 AM
undefined%
Bid n/a
Market Cap 7.14K
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.36
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask n/a
Volume 200
Avg. Volume (20D) 20,637
Open 0.00
Previous Close 0.00
Day's Range 0.00 - 0.00
52-Week Range 0.00 - 0.13
Beta undefined

About STAB

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential imm...

Industry Biotechnology
Sector Healthcare
IPO Date Jul 28, 2021
Employees 46
Stock Exchange NASDAQ
Ticker Symbol STAB